These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

9690 related items for PubMed ID: 16893501

  • 1. Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes.
    Hao S, Bai O, Yuan J, Qureshi M, Xiang J.
    Cell Mol Immunol; 2006 Jun; 3(3):205-11. PubMed ID: 16893501
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity.
    Hao S, Bai O, Li F, Yuan J, Laferte S, Xiang J.
    Immunology; 2007 Jan; 120(1):90-102. PubMed ID: 17073943
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tumor cell-derived exosome-targeted dendritic cells stimulate stronger CD8+ CTL responses and antitumor immunities.
    Yao Y, Chen L, Wei W, Deng X, Ma L, Hao S.
    Biochem Biophys Res Commun; 2013 Jun 21; 436(1):60-5. PubMed ID: 23707941
    [Abstract] [Full Text] [Related]

  • 6. Tumor apoptotic bodies inhibit CTL responses and antitumor immunity via membrane-bound transforming growth factor-beta1 inducing CD8+ T-cell anergy and CD4+ Tr1 cell responses.
    Xie Y, Bai O, Yuan J, Chibbar R, Slattery K, Wei Y, Deng Y, Xiang J.
    Cancer Res; 2009 Oct 01; 69(19):7756-66. PubMed ID: 19789353
    [Abstract] [Full Text] [Related]

  • 7. Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells.
    Chen W, Wang J, Shao C, Liu S, Yu Y, Wang Q, Cao X.
    Eur J Immunol; 2006 Jun 01; 36(6):1598-607. PubMed ID: 16708399
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells.
    Dai S, Wan T, Wang B, Zhou X, Xiu F, Chen T, Wu Y, Cao X.
    Clin Cancer Res; 2005 Oct 15; 11(20):7554-63. PubMed ID: 16243831
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The immunogenicity of dendritic cell-derived exosomes.
    Quah BJ, O'Neill HC.
    Blood Cells Mol Dis; 2005 Oct 15; 35(2):94-110. PubMed ID: 15975838
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
    Liu Y, Huang H, Chen Z, Zong L, Xiang J.
    J Gene Med; 2003 Aug 15; 5(8):668-80. PubMed ID: 12898636
    [Abstract] [Full Text] [Related]

  • 15. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors.
    Ye Z, Shi M, Chan T, Sas S, Xu S, Xiang J.
    Cancer Gene Ther; 2007 Jul 15; 14(7):661-75. PubMed ID: 17479109
    [Abstract] [Full Text] [Related]

  • 16. Intradermal vaccination of dendritic cell-derived exosomes is superior to a subcutaneous one in the induction of antitumor immunity.
    Hao S, Ye Z, Yang J, Bai O, Xiang J.
    Cancer Biother Radiopharm; 2006 Apr 15; 21(2):146-54. PubMed ID: 16706635
    [Abstract] [Full Text] [Related]

  • 17. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
    Strome SE, Voss S, Wilcox R, Wakefield TL, Tamada K, Flies D, Chapoval A, Lu J, Kasperbauer JL, Padley D, Vile R, Gastineau D, Wettstein P, Chen L.
    Cancer Res; 2002 Mar 15; 62(6):1884-9. PubMed ID: 11912169
    [Abstract] [Full Text] [Related]

  • 18. Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines.
    Okada H, Tsugawa T, Sato H, Kuwashima N, Gambotto A, Okada K, Dusak JE, Fellows-Mayle WK, Papworth GD, Watkins SC, Chambers WH, Potter DM, Storkus WJ, Pollack IF.
    Cancer Res; 2004 Aug 15; 64(16):5830-8. PubMed ID: 15313927
    [Abstract] [Full Text] [Related]

  • 19. Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge.
    Krishnan L, Sad S, Patel GB, Sprott GD.
    Cancer Res; 2003 May 15; 63(10):2526-34. PubMed ID: 12750276
    [Abstract] [Full Text] [Related]

  • 20. [Ad hTRP2 - mediated immunity against melanoma is enhanced by dendritic cells pulsed with peptide].
    Tan XH, Liu C, Wan YH.
    Zhonghua Zhong Liu Za Zhi; 2006 Sep 15; 28(9):658-61. PubMed ID: 17274369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 485.